Silence Therapeutics plc ( SLN) - Key Metrics
SLN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0 | -$0.25 | -$0.37 | -$0.37 |
| 2025Q3 | $0.01 | -$1.33 | -$0.69 | -$0.69 |
| 2025Q2 | $0.01 | -$1.74 | -$1.38 | -$1.39 |
| 2025Q1 | $0.01 | -$1.81 | -$0.78 | -$0.78 |
SLN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -6.10 |
| 2025Q3 | ? | -0.97 |
| 2025Q2 | ? | -0.83 |
| 2025Q1 | ? | -0.39 |
SLN
Price: $6.69
52 week price:
Earnings Per Share: -1.62 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 18800
Market Capitalization: 302.8 million